Clinical trial
A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With…
NCT00162032 · Lantheus Medical Imaging, Industry · Completed
Key facts
| NCT number | NCT00162032 |
|---|---|
| Title | A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease |
| Official title | A Phase III, Open-Label, Non-Randomized, International, Multicenter Trial to Evaluate the Efficacy and Safety of CARDIOLITE® Myocardial Perfusion Imaging in Pediatric Subjects With Kawasaki Disease |
| Lead sponsor | Lantheus Medical Imaging, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kawasaki Disease |
| Intervention type | Drug |
| Interventions | Sestamibi |
| Enrollment | 445 |
| Start date | Aug 1, 2005 |
| Primary completion | May 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Sep 13, 2005 |
| Last update posted | Jul 23, 2019 |
| Countries | Brazil, Canada, Philippines, South Korea, Taiwan, Thailand, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: